Neil Herskowitz, Director at AVENUE THERAPEUTICS, INC. (ATXI), bought 500 shares at $5.24 ($3K) on 2017-10-09, disclosed to the SEC on 2017-10-10.
Open-market purchase of $3k ATXI by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| ATXI | BUY | 2021-05-07 | $10K | — | Filing → |
| ATXI | BUY | 2020-03-02 | $21K | — | Filing → |
| ATXI | BUY | 2020-02-25 | $93K | — | Filing → |